Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-9057 in Heart Failure-induced Fluid Retention
NCT07318103Phase 2Recruiting
- Sponsor
- Fujian Shengdi Pharmaceuticals
- Start
- Dec 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-9057 in edema, sponsored by Fujian Shengdi Pharmaceuticals. Started Dec 2025; status: recruiting.
02
Drugs
HRS-9057
03
Conditions
edema
Beyond the preview
Go deeper on NCT07318103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07318103.